Cairn Diagnostics to Speak at Q1 Productions’ Diagnostic Coverage & Reimbursement Conference

We’re proud to announce that Cairn Diagnostics will be participating in the upcoming 32nd Tri-Annual Diagnostic Coverage & Reimbursement Conference, hosted by Q1 Productions on March 18–19, 2026 in San Diego, CA at The Alma.

This premier event brings together leaders across the diagnostics landscape—from laboratory innovators and regulatory experts to payer strategists and healthcare providers—all focused on shaping the future of diagnostic access, reimbursement, and innovation.

Representing Cairn Diagnostics:

Our own Kerry Bush will be joining the conversation, contributing insights on the evolving role of diagnostics in improving access, streamlining reimbursement models, and supporting value-based care delivery.

As the creators of the Gastric Emptying Breath Test (GEBT)—the first and only FDA-approved, non-radioactive, ACG and AGA guideline-supported breath test for gastroparesis—we’re excited to share how innovation in testing can lead to broader access and more equitable care.

“Diagnostics are foundational to timely, effective care—but only when patients can access and afford them. This conference is a space to tackle those barriers head-on, and we’re proud to be part of that dialogue.”
— Kerry Bush, President & COO, Cairn Diagnostics